Amyloidosis Treatment Market - Monoclonal Antibody Therapy...

agregó una foto Health

2026-07-20 07:42:58 -

Amyloidosis Treatment Market - Monoclonal Antibody Therapy Advancing AL Amyloidosis Plasma Cell Targeting

Market Overview The amyloidosis treatment market is plasma-targeting as monoclonal antibody therapy advances AL amyloidosis plasma cell targeting. The Amyloidosis Treatment Market is projected to grow through 2030, driven by light chain amyloidosis recognition, daratumumab anti-CD38 antibody efficacy, bortezomib-based regimen optimization, and stem cell transplant eligibility expansion...

0 Commentarios 0 Acciones 3 Views 0 Vista previa